Vijaya Doddi
About Vijaya Doddi
Vijaya Doddi is a Scientist III at IGM Biosciences, Inc., with extensive experience in the biopharmaceutical industry, including previous roles at Five Prime Therapeutics and Boehringer Ingelheim. She specializes in small scale cell culture techniques and has a strong background in supporting purification processes.
Current Role at IGM Biosciences
Vijaya Doddi serves as Scientist III at IGM Biosciences, Inc. since 2021. Based in Mountain View, California, she has been involved in various projects that leverage her expertise in biopharmaceuticals. Her role includes applying advanced techniques in cell culture and contributing to the development of therapeutic proteins.
Previous Experience at Five Prime Therapeutics
Before her current position, Vijaya Doddi worked as a Senior Research Associate at Five Prime Therapeutics for six months in 2010. Located in South San Francisco, California, her responsibilities included conducting research that supported the company's therapeutic development initiatives.
Professional Background in Biopharmaceuticals
Vijaya Doddi has extensive experience in the biopharmaceutical industry. She worked at Boehringer Ingelheim from 2014 to 2021 as a Scientist in Cell Culture Process Development. Prior to that, she held positions at various organizations, including Medimmune, Bayer, and Elan Pharmaceuticals, where she focused on research and development in cell culture techniques.
Education and Expertise
Vijaya Doddi earned her M.S. from The University of New Mexico School of Medicine, studying from 1999 to 2001. She specializes in small scale cell culture techniques, including spinner flasks, shake flasks, T-flasks, and Applikon Bioreactors. Her expertise extends to supporting purification processes by providing cell culture-derived influenza virus and therapeutic proteins.
Achievements in Cell Culture Techniques
Throughout her career, Vijaya Doddi has improved product titer without compromising product quality across various projects. Her contributions have been significant in enhancing the efficiency of biopharmaceutical processes, demonstrating her commitment to advancing the field.